Benzinga.com

EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation on Wednesday, earlier than previously guided. NeuroOne Medical is ...
Seeking Alpha

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...
MedPage Today

Rapid Improvement in Overactive Bladder With Transvaginal RF Nerve Ablation

LAS VEGAS -- Overactive bladder (OAB) symptoms in women improved rapidly and significantly following a single treatment with transvaginal radiofrequency (RF) nerve ablation, a small prospective study ...
Seeking Alpha

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

EDEN PRAIRIE, Minn., April 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...
Medical News Today

What to know about vagus nerve stimulation

VNS is the process of electrically stimulating the vagus nerve via a surgically implanted device. It is generally safe, but may cause temporary side effects, such as hoarseness, coughing, and ...